Amphista Therapeutics Limited – Trademark Portfolio
Entity Type: 11
Amphista Therapeutics Limited holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AMPHISTA, ECLIPSYS, and TARGETED GLUE. The owner is based in Zurich.
Bahnhofstrasse 52
Zurich CH-8001 , CH
Showing of trademarks Trademarks
Trademark Classifications
Amphista Therapeutics Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Amphista Therapeutics Limited have?
Amphista Therapeutics Limited has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Amphista Therapeutics Limited file in?
Amphista Therapeutics Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Amphista Therapeutics Limited's most well-known trademarks?
Amphista Therapeutics Limited's registered trademark portfolio includes well-known marks such as AMPHISTA, ECLIPSYS, and TARGETED GLUE. These are among 4 currently registered trademarks in the portfolio.
What is Amphista Therapeutics Limited's trademark registration success rate?
Amphista Therapeutics Limited has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.